Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

被引:0
|
作者
Ye Qing [1 ]
Yuan Xiaolei [1 ]
Zhou Jie [1 ]
Yuan Canxing [1 ]
Yang Xuming [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Neurol, Shanghai 200032, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Dept Acupuncture Inst, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
MAP kinase signaling system; Inflammation; Apoptosis; Parkinsondisease; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MOUSE MODEL; CELL-DEATH; JNK; INHIBITION; ACTIVATION; EXPRESSION; SUBACUTE;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To investigate the regulatory mechanism of the c-Jun N-terminal protein kinase (JNK) signaling pathway in substantia nigra (SN) dopaminergic neurons inflammation and apoptosis, and the neuroprotective effect of Zishenpingchan granules in mice with Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). METHODS: PD model mice were established by intraperitoneally injecting MPTP. Sixty mice were divided into a model group, Traditional Chinese Medicine (TCM) group and control group. The mice of the TCM group were administered Zishenpingchan granules 7 days before PD induction. Seven days after PD induction, we examined locomotor activity, and performed the rotarod test and swimming test, to evaluate limb movement function. Furthermore, we used immunohistochemistry and western blotting to examine the expression of tyrosine hydroxylase (TH), cyclooxygenase-2 (Cox-2), caspase-3 and p-JNK. The terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method was used to examine neuron apoptosis in the SN. RESULTS: Compared with the control group, the mean score of locomotor activity, rotarod test and swimming test was significantly lower in the model group (P < 0.05); the TH-positive neuron expression was significantly decreased in the SN pars compacta (SNpc); the protein expression levels of Cox-2, caspase-3 and p-JNK was obviously increased; and the number of TUNEL-positive neurons in the SN was increased (P < 0.01). Compared with the model group, the mean score of neurobehavioral tests in the TCM group was obviously higher, the loss of TH-positive neurons ignificantly decreased, the protein expression levels of Cox-2, caspase-3 and p-JNK obviously decreased, and the number of TUNEL-positive neurons in the SN clearly decreased (P < 0.01). CONCLUSION: The JNK pathway plays an important role in the regulation of inflammation and apoptosis in nigral cells in PD mice. TCM can suppress the over-activation of the JNK pathway in the SN, and alleviate the inflammatory response in nigral cells and dopaminergic neuron apoptosis in PD mice. (C) 2017 JTCM. All rights reserved.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 50 条
  • [11] Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
    Park, Jihye
    Lim, Chae-Seok
    Seo, Hyunhyo
    Park, Chung-Ah
    Zhuo, Min
    Kaang, Bong-Kiun
    Lee, Kyungmin
    MOLECULAR PAIN, 2015, 11
  • [12] Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
    Nishi, K
    BRAIN RESEARCH, 1997, 771 (01) : 133 - 141
  • [13] Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease
    Ray, SK
    Wilford, GG
    Ali, SF
    Banik, NL
    NEUROBIOLOGICAL MECHANISMS OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 2000, 914 : 275 - 283
  • [14] Neuroprotective effect of glycyrrhizin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
    Kim, D. E.
    Park, S. E.
    Han, J. H.
    JOURNAL OF NEUROLOGY, 2008, 255 : 165 - 165
  • [15] Therapeutic effect of zonisamide on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-treated mice model of Parkinson's disease
    Yokoyama, Hironori
    Yano, Ryohei
    Kato, Hiroyuki
    Araki, Tsutomu
    Kasahara, Jiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 115P - 115P
  • [16] AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Choi, Jae-Sun
    Park, Chan
    Jeong, Joo-Won
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 147 - 151
  • [17] Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease
    Goldstein, DS
    Li, ST
    Holmes, C
    Bankiewicz, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 855 - 860
  • [18] Ameliorating effect of dimethylsulfoniopropionate on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease of mice
    Nakajima, K
    Minematsu, M
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2006, 52 (01) : 70 - 74
  • [19] Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Han, Bing
    Che, Xin
    Zhao, Yue
    Li, Cuiting
    He, Jie
    Lu, Yan
    Wang, Zhenhua
    Wang, Tian
    BEHAVIOURAL PHARMACOLOGY, 2019, 30 (01): : 36 - 44
  • [20] The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mice myocardial morphology
    Sasahara, Tais H. C.
    Machado, Marcia R. F.
    PESQUISA VETERINARIA BRASILEIRA, 2019, 39 (05): : 364 - 370